Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive

Tempus AI has committed to acquiring cancer diagnostics company Personalis for $1.5 billion, with the announcement made on Monday. However, the stocks of both medical technology firms experienced a decline in value following the news. This acquisition marks a significant move in the industry, emphasizing Tempus AI's strategic expansion efforts.